Palo Alto, CA, United States of America

Sung-Yong S Cho

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung-Yong S Cho. Retrieved from https://idiyas.com/inventor/sung-yong-s-cho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sung-Yong S Cho

Introduction

Sung-Yong S Cho is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target physiological disorders.

Latest Patents

One of his notable patents is for 2-acylaminopropanamides as tachykinin receptor antagonists. This invention provides a series of novel substituted propanamides that are useful in the treatment or prevention of physiological disorders associated with an excess of tachykinins. The patent also outlines methods for treating such disorders and includes pharmaceutical formulations that utilize these innovative compounds. He holds 1 patent in this area.

Career Highlights

Sung-Yong S Cho is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work focuses on developing therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Philip Arthur Hipskind and J Jeffry Howbert. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Sung-Yong S Cho's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of physiological disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…